Connection

Pål Aukrust to Chemokine CXCL10

This is a "connection" page, showing publications Pål Aukrust has written about Chemokine CXCL10.
Connection Strength

0.134
  1. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1ß in non-ST-elevation myocardial infarction. Int J Cardiol. 2018 Nov 15; 271:1-7.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.